Adding Insult to Injury: Does COVID-19 Promote Acute Respiratory Distress Syndrome by Inhibiting Surfactant?

Bradley W Richmond^{1

2

3}, Charles S Dela Cruz^{4

5

6}

Affiliations

¹ Department of Veterans Affairs Nashville, Tennessee.
² Division of Allergy, Pulmonary, and Critical Care Medicine Vanderbilt University Medical Center Nashville, Tennessee.
³ Department of Cell and Developmental Biology Vanderbilt University Nashville, Tennessee.
⁴ Department of Internal Medicine.
⁵ Department of Microbial Pathogenesis Yale University New Haven, Connecticut.
⁶ Veterans Affairs Connecticut Healthcare Systems West Haven, Connecticut.

Editorial

Bradley W Richmond et al. Am J Respir Crit Care Med. 2023.

. 2023 Jan 1;207(1):5-6.

doi: 10.1164/rccm.202208-1549ED.

Bradley W Richmond^{1

2

3}, Charles S Dela Cruz^{4

5

6}

¹ Department of Veterans Affairs Nashville, Tennessee.
² Division of Allergy, Pulmonary, and Critical Care Medicine Vanderbilt University Medical Center Nashville, Tennessee.
³ Department of Cell and Developmental Biology Vanderbilt University Nashville, Tennessee.
⁴ Department of Internal Medicine.
⁵ Department of Microbial Pathogenesis Yale University New Haven, Connecticut.
⁶ Veterans Affairs Connecticut Healthcare Systems West Haven, Connecticut.

No abstract available

Comment on

Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Sinnberg T, Lichtensteiger C, Ali OH, Pop OT, Jochum AK, Risch L, Brugger SD, Velic A, Bomze D, Kohler P, Vernazza P, Albrich WC, Kahlert CR, Abdou MT, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat SM, Ruetalo N, Buehler PK, Scheier TC, Jochum W, Kern L, Henz S, Schneider T, Kuster GM, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan-Marra N, Kalbacher H, McCoy KD, Spengler W, Brutsche MH, Maček B, Twerenbold R, Penninger JM, Matter MS, Flatz L. Sinnberg T, et al. Am J Respir Crit Care Med. 2023 Jan 1;207(1):38-49. doi: 10.1164/rccm.202201-0011OC. Am J Respir Crit Care Med. 2023. PMID: 35926164 Free PMC article.

1. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J . 1999;13:1455–1476. - PubMed
1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child . 1959;97:517–523. - PubMed
1. Rüfer R. The influence of surface active substances on alveolar mechanics in the respiratory distress syndrome. Respiration . 1968;25:441–457. - PubMed
1. Polin RA, Carlo WA, Committee on Fetus and Newborn American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics . 2014;133:156–163. - PubMed
1. World Health Organization . Geneva, Switzerland: World Health Organization; 2020. https://covid19.who.int